Comparing two methods for collecting bone marrow in hip surgery
Comparison of the Constituents of Bone Marrow Aspirate and Autologous Protein Solution Collected With a Traditional and a Novel System
NA · Ohio State University · NCT06388993
This study is testing a new way to collect bone marrow during hip surgery to see if it works better than the standard method for helping patients with bone loss heal.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 6 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Ohio State University (other) |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT06388993 on ClinicalTrials.gov |
What this trial studies
This study involves six patients with bone loss in the hip who will undergo minimally invasive repair. Participants will have bone marrow collected from both the surgical and non-surgical hips using two different systems: the standard Zimmer Biomet Biocue system and the novel Marrow Cellutions system™. The collected bone marrow will be processed to concentrate the cells and molecules, with the concentrated liquid from the surgical hip being delivered to promote healing. The goal is to evaluate the effectiveness of the new collection method compared to the traditional approach.
Who should consider this trial
Good fit: Ideal candidates are patients aged 18 to 50 who are undergoing hip arthroscopy for subchondral bone cysts or avascular necrosis.
Not a fit: Patients with a history of hematologic issues, diabetes, or previous bone marrow aspirate may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance healing outcomes for patients undergoing hip arthroscopy.
How similar studies have performed: While this approach is novel, similar studies have shown promise in improving outcomes with bone marrow interventions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients aged 18 - 50 * patients undergoing hip arthroscopy for subchondral bone cysts and/or avascular necrosis Exclusion Criteria: * patients with a history of hematologic issues including anemia and sickle cell anemia * patients with a history of leukemia, lymphoma, or other bone marrow related diseases * patients with diabetes * patients with a history of bone marrow aspirate
Where this trial is running
Columbus, Ohio
- Jameson Crane Sports Medicine Institute — Columbus, Ohio, United States (RECRUITING)
Study contacts
- Principal investigator: William K Vasileff, MD — Ohio State University
- Study coordinator: Michael Keller
- Email: michael.keller@osumc.edu
- Phone: 614-293-2410
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hip Arthropathy, Avascular Necrosis of Bone, Subchondral Cysts